SCHEMBL5658903

SCHEMBL5658903

CN(C)CC[CH]CC1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7138787 0.76 GBA1 (0.38)
SCHEMBL249671 0.73 SIGMAR1 (0.42)
SCHEMBL27363514 0.73 GNAO1 (0.36)
Hydrochloric Acid SCHEMBL8690390 0.71 SIGMAR1 (0.41)
Hydrochloric Acid SCHEMBL28238994 0.71 SIGMAR1 (0.41)
SCHEMBL9728089 0.69 SIGMAR1 (0.53)
Hydrochloric Acid SCHEMBL11715631 0.68 SIGMAR1 (0.52)
SCHEMBL15698399 0.68 CA12 (0.40)
SCHEMBL16312419 0.68 SIGMAR1 (0.62)
SCHEMBL27527086 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7226950-B2 Sodium channel modulators THERAVANCE, INC. (US) 2007-06-05 US disclosed